AETX-R114

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameAETX-R114

Drug Alias NameAETX-R114

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionCD3 T-cell engagersKRAS G12C inhibitors

TargetsT cell surface glycoprotein CD3KRAS G12C

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAethon Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAethon Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A